David Barras

11PUBLICATIONS
102CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersTumour immunologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Nov 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors.

Doga C Gulhan, David Barras, Marco Mina

|Nov 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.

Anais Elewaut, Guillem Estivill, Felix Bayerl

|May 07, 2024
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.

Rémy Pétremand, Johanna Chiffelle, Sara Bobisse

|Apr 24, 2024
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.

Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope

|Feb 02, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.

David Barras, Eleonora Ghisoni, Johanna Chiffelle

Pageof 2

Frequent Collaborators

8 joint publications

George Coukos

6 joint publications

Lana E Kandalaft

6 joint publications

Alexandre Harari

6 joint publications

Michal Bassani-Sternberg